Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22977717 | 1.00 | CNR1 (0.34) | CNR1CNR2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL31606406 | 1.00 | CNR1 (0.34) | CNR1CNR2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL31606363 | 1.00 | CNR1 (0.34) | CNR1CNR2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL22977706 | 0.87 | SMN1; SMN2 (0.33) | CNR1CNR2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL21178996 | 0.87 | SMN1; SMN2 (0.33) | CNR1CNR2SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL22977719 | 0.81 | SMN1; SMN2 (0.31) | SMN1; SMN2LMNA | |
| SCHEMBL31606378 | 0.81 | SMN1; SMN2 (0.31) | SMN1; SMN2LMNA | |
| SCHEMBL31606403 | 0.70 | SMN1; SMN2 (0.35) | SMN1; SMN2LMNAALDH1A1KDM4E | |
| SCHEMBL22977705 | 0.70 | SMN1; SMN2 (0.35) | SMN1; SMN2LMNAALDH1A1KDM4E | |
| SCHEMBL18797608 | 0.67 | CDK8 (0.40) | SMN1; SMN2LMNAALDH1A1MEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | FMC CORP (US) | 2021-02-18 | — | — | US | claimed |
| US-20260098020-A1 | HERBICIDAL PYRIMIDINYLMETHYL-SUBSTITUTED 1,2,4-TRIAZOLES | FMC CORP (US) | 2026-04-09 | — | — | US | disclosed |
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | FMC CORP (US) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045385-A1 | PYRIDAZINONE-SUBSTITUTED KETOXIMES AS HERBICIDES | CYP1A2, CYP1B1, CYP1A1 | CNR1 630/4885CNR2 504/4885SMN1; SMN2 4480/4885 |
| US-20260098020-A1 | HERBICIDAL PYRIMIDINYLMETHYL-SUBSTITUTED 1,2,4-TRIAZOLES | CBR3, CBR1, CNPY3 | CNR1 30/4885CNR2 74/4885SMN1; SMN2 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.